Agha AM, Parwani P, Guha A, et al. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart 2018; 5:e000881. doi:10.1136 / openhrt-2018 This article has been corrected since it first published. The authors want to inform the readers on the following two changes.
The second paragraph under the sub-heading 'Late gadolinium enhancement' of 'Cardiovascular magnetic resonance', should read as:
Although a very useful technique, a challenge with LGE is to choose an appropriate inversion time (TI) value. This TI value is a baseline where the myocardium is black or 'nulled'. Incorrect determination of this null point may mask evidence of amyloidosis. 27 A technique called 'phase-sensitive inversion recovery' allows for the automated determination of an ideal TI time and may prevent user error from incorrectly masking amyloidosis on CMR 27 (see figure 4) . The third paragraph under the sub-heading 'T1 mapping' of 'Cardiovascular magnetic resonance', should read as:
A pre-contrast T1 time of greater than 1044 ms has been associated with a poor prognosis in AL amyloidosis. 31 A similar cut-off of greater than 1077 ms has been associated with worse prognosis for ATTR amyloidosis, but not particularly prognostic when separated by familial and wild-type ATTR. Correction
